Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $64.5B
1-Year Est. Return 42.74%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+42.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$64.5B
AUM Growth
-$11.3B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,923
New
Increased
Reduced
Closed

Top Buys

1 +$616M
2 +$481M
3 +$416M
4
TSLA icon
Tesla
TSLA
+$416M
5
PG icon
Procter & Gamble
PG
+$322M

Top Sells

1 +$885M
2 +$660M
3 +$463M
4
APP icon
Applovin
APP
+$430M
5
META icon
Meta Platforms (Facebook)
META
+$354M

Sector Composition

1 Technology 20.85%
2 Healthcare 15.77%
3 Consumer Discretionary 13.88%
4 Industrials 9.93%
5 Financials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXG icon
501
10x Genomics
TXG
$2.94B
$25.3M 0.04%
1,550,539
+505,618
CORZ icon
502
Core Scientific
CORZ
$5.67B
$25.2M 0.04%
1,730,463
+175,177
DLTR icon
503
Dollar Tree
DLTR
$20.8B
$25.2M 0.04%
204,703
-937,600
MBC icon
504
MasterBrand
MBC
$1.06B
$25.1M 0.04%
2,271,863
+158,500
G icon
505
Genpact
G
$6.27B
$25.1M 0.04%
536,000
+4,000
FWONA icon
506
Liberty Media Series A
FWONA
$20.4B
$25.1M 0.04%
280,522
-38,500
PRLB icon
507
Protolabs
PRLB
$1.44B
$25M 0.04%
493,551
-50,100
SRPT icon
508
Sarepta Therapeutics
SRPT
$2.33B
$25M 0.04%
1,159,578
-1,490,600
FTI icon
509
TechnipFMC
FTI
$29.4B
$24.9M 0.04%
558,500
-369,900
ANIP icon
510
ANI Pharmaceuticals
ANIP
$1.77B
$24.8M 0.04%
314,402
+41,500
CRS icon
511
Carpenter Technology
CRS
$21.3B
$24.8M 0.04%
78,800
-53,600
WMG icon
512
Warner Music
WMG
$14.4B
$24.8M 0.04%
808,222
-335,378
SOLV icon
513
Solventum
SOLV
$11.3B
$24.8M 0.04%
312,800
+161,000
PFGC icon
514
Performance Food Group
PFGC
$13.8B
$24.8M 0.04%
275,307
-172,700
EBF icon
515
Ennis
EBF
$559M
$24.6M 0.04%
1,368,146
-93,800
CALX icon
516
Calix
CALX
$3.22B
$24.5M 0.04%
463,618
+202,800
MYE icon
517
Myers Industries
MYE
$821M
$24.5M 0.04%
1,308,590
-20,407
OSW icon
518
OneSpaWorld
OSW
$2.47B
$24.5M 0.04%
1,180,340
-91,300
COGT icon
519
Cogent Biosciences
COGT
$6.06B
$24.5M 0.04%
689,068
+456,100
VEEV icon
520
Veeva Systems
VEEV
$25.7B
$24.5M 0.04%
109,640
-78,360
CDTX
521
DELISTED
Cidara Therapeutics
CDTX
$24.4M 0.04%
110,560
+6,300
ZS icon
522
Zscaler
ZS
$19.7B
$24.4M 0.04%
108,300
+2,800
GSL icon
523
Global Ship Lease
GSL
$1.4B
$24.3M 0.04%
693,350
-145,200
PM icon
524
Philip Morris
PM
$251B
$24.2M 0.04%
+150,900
BMI icon
525
Badger Meter
BMI
$4.5B
$24.1M 0.04%
138,400
-58,800